1. Home
  2. RVMDW vs OCEAW Comparison

RVMDW vs OCEAW Comparison

Compare RVMDW & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • OCEAW
  • Stock Information
  • Founded
  • RVMDW N/A
  • OCEAW N/A
  • Country
  • RVMDW United States
  • OCEAW United States
  • Employees
  • RVMDW 490
  • OCEAW 9
  • Industry
  • RVMDW
  • OCEAW Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVMDW
  • OCEAW Health Care
  • Exchange
  • RVMDW Nasdaq
  • OCEAW Nasdaq
  • Market Cap
  • RVMDW N/A
  • OCEAW N/A
  • IPO Year
  • RVMDW N/A
  • OCEAW 2021
  • Fundamental
  • Price
  • RVMDW $0.15
  • OCEAW $0.03
  • Analyst Decision
  • RVMDW
  • OCEAW
  • Analyst Count
  • RVMDW 0
  • OCEAW 0
  • Target Price
  • RVMDW N/A
  • OCEAW N/A
  • AVG Volume (30 Days)
  • RVMDW N/A
  • OCEAW N/A
  • Earning Date
  • RVMDW N/A
  • OCEAW N/A
  • Dividend Yield
  • RVMDW N/A
  • OCEAW N/A
  • EPS Growth
  • RVMDW N/A
  • OCEAW N/A
  • EPS
  • RVMDW N/A
  • OCEAW N/A
  • Revenue
  • RVMDW N/A
  • OCEAW N/A
  • Revenue This Year
  • RVMDW N/A
  • OCEAW N/A
  • Revenue Next Year
  • RVMDW N/A
  • OCEAW N/A
  • P/E Ratio
  • RVMDW N/A
  • OCEAW N/A
  • Revenue Growth
  • RVMDW N/A
  • OCEAW N/A
  • 52 Week Low
  • RVMDW N/A
  • OCEAW N/A
  • 52 Week High
  • RVMDW N/A
  • OCEAW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • OCEAW N/A
  • Support Level
  • RVMDW N/A
  • OCEAW N/A
  • Resistance Level
  • RVMDW N/A
  • OCEAW N/A
  • Average True Range (ATR)
  • RVMDW 0.00
  • OCEAW 0.00
  • MACD
  • RVMDW 0.00
  • OCEAW 0.00
  • Stochastic Oscillator
  • RVMDW 0.00
  • OCEAW 0.00

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About OCEAW Ocean Biomediacal Inc.

Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.

Share on Social Networks: